in Tag: Clinical Trials  (clear all)


Found 3 results

Showing 1 to 3

Post-Marketing Reporting of Adverse Drug Reactions to Human Medicinal Products in South Africa (MCC: 2.33, Sept 2016)

The document assist the reporting of adverse drug reactions (ADRs) and in the management of safety data during post-registration and post-marketing clinical trials. To confirm that you have the latest version of this document, please visit: http://www.mccza.com

Related Tags (New Search): SafetyAdverse Drug ReactionClinical trialsMedicines

Good Clinical Practices: Emergency Trolley (MCC: 9.60, Jun 2015)

Requirement for all site conducting clinical trials to have an emergency trolley. Please note that this is a third-party website. Juta has no control over the nature, content or availability of third-party websites, and shall not be liable, in any manner…

Related Tags (New Search): SafetyEmergencyClinical trials

Reporting Adverse Drug Reactions in South Africa (MCC: 2.11, Dec 2012)

This guideline apply to the reporting of serious adverse event of medicine reported during clinical trial. It does not apply to the reporting of post-marketing adverse drug reaction. Refer to guideline 2.33 for the reporting of post-marketing adverse reactions to…

Related Tags (New Search): Clinical trials